James Zou, PhD, elaborates on some of the challenges associated with machine learning techniques and its utilization in oncology.
James Zou, PhD
Advertisement
Articles by James Zou, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Poll Results Reveal Readers’ Top Abstracts at ASH 2025
3
FDA Approves Liso-Cel as First CAR T-Cell Therapy for Marginal Zone Lymphoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
